Amanda Croft

1.2k total citations
34 papers, 888 citations indexed

About

Amanda Croft is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Amanda Croft has authored 34 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Amanda Croft's work include Cell death mechanisms and regulation (7 papers), Endoplasmic Reticulum Stress and Disease (7 papers) and Autophagy in Disease and Therapy (5 papers). Amanda Croft is often cited by papers focused on Cell death mechanisms and regulation (7 papers), Endoplasmic Reticulum Stress and Disease (7 papers) and Autophagy in Disease and Therapy (5 papers). Amanda Croft collaborates with scholars based in Australia, China and United Kingdom. Amanda Croft's co-authors include Xu Dong Zhang, Chen Chen Jiang, Peter Hersey, Hsin‐Yi Tseng, Lei Jin, Kwang Hong Tay, Su Guo, Fan Yang, Fritz Lai and Helen Rizos and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Amanda Croft

33 papers receiving 880 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amanda Croft Australia 17 559 207 206 166 127 34 888
Roger H. Kim United States 17 649 1.2× 373 1.8× 164 0.8× 90 0.5× 95 0.7× 46 1.3k
Jiazhi Liao China 20 687 1.2× 179 0.9× 90 0.4× 249 1.5× 77 0.6× 62 1.3k
Naomi Yoshida Japan 18 264 0.5× 80 0.4× 82 0.4× 65 0.4× 157 1.2× 54 862
Martin A Martino United States 12 475 0.8× 291 1.4× 66 0.3× 72 0.4× 45 0.4× 23 1.2k
Dale Vimalachandran United Kingdom 18 332 0.6× 380 1.8× 60 0.3× 38 0.2× 66 0.5× 69 931
Dineo Khabele United States 19 584 1.0× 373 1.8× 26 0.1× 91 0.5× 190 1.5× 62 1.2k
Aneel Paulus United States 21 611 1.1× 389 1.9× 53 0.3× 141 0.8× 185 1.5× 93 1.3k
Steven Donahue United States 5 281 0.5× 189 0.9× 123 0.6× 71 0.4× 43 0.3× 13 827
Ahmed Zaid Sweden 13 582 1.0× 166 0.8× 109 0.5× 78 0.5× 168 1.3× 24 1.4k
Stephen M. Schleicher United States 19 609 1.1× 373 1.8× 141 0.7× 117 0.7× 194 1.5× 62 1.3k

Countries citing papers authored by Amanda Croft

Since Specialization
Citations

This map shows the geographic impact of Amanda Croft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Croft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Croft more than expected).

Fields of papers citing papers by Amanda Croft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Croft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Croft. The network helps show where Amanda Croft may publish in the future.

Co-authorship network of co-authors of Amanda Croft

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Croft. A scholar is included among the top collaborators of Amanda Croft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Croft. Amanda Croft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Dongqing, et al.. (2025). Anti-cancer agent Olaparib ameliorates doxorubicin-induced cardiotoxicity in vitro and in vivo. Journal of Molecular and Cellular Cardiology. 206. 114–126.
2.
Haw, Tatt Jhong, Amanda Croft, Dongqing Chen, et al.. (2025). Identifying common pathways for doxorubicin and carfilzomib-induced cardiotoxicities: transcriptomic and epigenetic profiling. Scientific Reports. 15(1). 4395–4395. 2 indexed citations
3.
Croft, Amanda, Dongqing Chen, Tatt Jhong Haw, et al.. (2024). Sex-based differences in short- and longer-term diet-induced metabolic heart disease. American Journal of Physiology-Heart and Circulatory Physiology. 326(5). H1219–H1251. 2 indexed citations
4.
Haw, Tatt Jhong, et al.. (2024). Cancer Therapies and Cardiomyocyte Viability: Which Drugs are Directly Cardiotoxic?. Heart Lung and Circulation. 33(5). 747–752. 7 indexed citations
6.
Chu, Matthew, Dongqing Chen, Amanda Croft, et al.. (2023). Association of Circulating Plasma Secreted Frizzled-Related Protein 5 (Sfrp5) Levels with Cardiac Function. Journal of Cardiovascular Development and Disease. 10(7). 274–274. 4 indexed citations
7.
Chen, Dongqing, et al.. (2023). Elevated Soluble Suppressor of Tumorigenicity 2 Predict Hospital Admissions Due to Major Adverse Cardiovascular Events (MACE). Journal of Clinical Medicine. 12(8). 2790–2790. 5 indexed citations
8.
Croft, Amanda, et al.. (2021). Follistatin-like 3 (FSTL3) levels are increased in acute heart failure patients. European Heart Journal. 42(Supplement_1). 2 indexed citations
9.
Chen, Dongqing, Tatt Jhong Haw, Janine Lombard, et al.. (2021). Heart Failure in Breast Cancer Survivors: Focus on Early Detection and Novel Biomarkers. Current Heart Failure Reports. 18(6). 362–377. 5 indexed citations
10.
Croft, Amanda, Su Guo, Margaret Farrelly, et al.. (2017). Functional identification of a novel transcript variant of INPP4B in human colon and breast cancer cells. Biochemical and Biophysical Research Communications. 485(1). 47–53. 4 indexed citations
11.
Wang, Yu Fang, Fen Liu, Margaret Farrelly, et al.. (2017). Cooperativity of HOXA5 and STAT3 Is Critical for HDAC8 Inhibition-Mediated Transcriptional Activation of PD-L1 in Human Melanoma Cells. Journal of Investigative Dermatology. 138(4). 922–932. 32 indexed citations
12.
Liu, Xiao Ying, Fritz Lai, Xu Guang Yan, et al.. (2015). RIP1 Kinase Is an Oncogenic Driver in Melanoma. Cancer Research. 75(8). 1736–1748. 58 indexed citations
13.
Lai, Fritz, Su Guo, Lei Jin, et al.. (2013). Cotargeting histone deacetylases and oncogenic BRAF synergistically kills human melanoma cells by necrosis independently of RIPK1 and RIPK3. Cell Death and Disease. 4(6). e655–e655. 39 indexed citations
14.
Jiang, Chen Chen, et al.. (2013). OBATOCLAX and ABT-737 Induce ER Stress Responses in Human Melanoma Cells that Limit Induction of Apoptosis. PLoS ONE. 8(12). e84073–e84073. 30 indexed citations
15.
Croft, Amanda, Hsin‐Yi Tseng, Su Guo, et al.. (2013). Repression of microRNA-768-3p by MEK/ERK signalling contributes to enhanced mRNA translation in human melanoma. Oncogene. 33(20). 2577–2588. 21 indexed citations
16.
Tay, Kwang Hong, Qi Luan, Amanda Croft, et al.. (2013). Sustained IRE1 and ATF6 signaling is important for survival of melanoma cells undergoing ER stress. Cellular Signalling. 26(2). 287–294. 77 indexed citations
17.
Croft, Amanda, Kwang Hong Tay, Suzanah C. Boyd, et al.. (2013). Oncogenic Activation of MEK/ERK Primes Melanoma Cells for Adaptation to Endoplasmic Reticulum Stress. Journal of Investigative Dermatology. 134(2). 488–497. 64 indexed citations
18.
Dong, Lei, Chen Chen Jiang, Rick F. Thorne, et al.. (2011). Ets-1 mediates upregulation of Mcl-1 downstream of XBP-1 in human melanoma cells upon ER stress. Oncogene. 30(34). 3716–3726. 60 indexed citations
19.
Jiang, Chen Chen, Fritz Lai, Kwang Hong Tay, et al.. (2010). Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimS. Cell Death and Disease. 1(9). e69–e69. 89 indexed citations
20.
Bowden, Nikola A., Amanda Croft, & Rodney J. Scott. (2007). Gene Expression Profiling in Familial Adenomatous Polyposis Adenomas and Desmoid Disease. Hereditary Cancer in Clinical Practice. 5(2). 79–79. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026